The more we know about our visitors, the easier it will be for us to publish everything you want to see.

Keep me logged in Forgot your password?

Please wait...

Please wait...

COSMEGEN

Compare COSMEGEN  to:
Compare
Compare

Generic Name for COSMEGEN

Dactinomycin 500mcg/vial; lyophilized pwd for IV inj or regional perfusion after reconstitution; contains mannitol; preservative-free.

Legal Classification:

Rx

Pharmacological Class for COSMEGEN

Actinomycin antibiotic.

Manufacturer of COSMEGEN

Lundbeck Inc.

Indications for COSMEGEN

Gestational trophoblastic neoplasia.

Other Indications for COSMEGEN

Adult dose for COSMEGEN

Give by IV infusion. 12mcg/kg daily for 5 days as a single agent; 500mcg on Days 1 and 2 as combination regimen with etoposide, methotrexate, folinic acid, vincristine, cyclophosphamide, and cisplatin. Max 15mcg/kg/day per 2-week cycle or 400–600mcg/m2/day for five days. Use surface area to calculate dose for obese or edematous patients.

Children's dosing for COSMEGEN

See literature.

Contraindications for COSMEGEN

Current or recent chickenpox or herpes zoster.

Warnings/Precautions for COSMEGEN

Myelosuppression; monitor bone marrow and hold treatment if platelets or WBCs decrease markedly. Extremely corrosive; avoid extravasation. Avoid skin, mucous membranes, eyes. Previous irradiation (esp. within 2 months of irradiation for treatment of right-sided Wilms' tumor), cytotoxic chemotherapy. Monitor renal and hepatic function. Obese. Elderly. Pregnancy (Cat.D); avoid use. Nursing mothers: not recommended.

Interactions for COSMEGEN

Avoid live vaccines. Concomitant radiotherapy in Wilms' tumor: not recommended.

Adverse Reactions for COSMEGEN

GI upset, stomatitis, bone marrow suppression (neutropenia, thrombocytopenia), liver toxicity, infusion site reactions, malaise, fatigue, alopecia, possible second primary tumors (including leukemia); for perfusion therapy: infection, impaired wound healing, superficial ulceration of gastric mucosa, edema, soft tissue damage, possible venous thrombosis.

How is COSMEGEN supplied?

Vials—1

Related Disease:

Cancer, testicular
Gestational trophoblastic neoplasia
Rhabdomyosarcoma
Wilms' tumor

Related Resources

Adjuvant Radiochemotherapy Has Lasting Benefit in Gastric Cancer

May 18, 2012

Patients with gastric cancer who undergo resection show survival benefit 10 years later.

Fertility-Related Information Urgently Needed for Female Patients with Cancer

May 18, 2012

Young adult males and females with cancer receive vastly different amounts of fertility-related and fertility preservation information.

STAT3 Mutations ID'd in Rare Lymphoproliferative Disorder

May 18, 2012

Four specific mutations in SH2 domain seen in T-cell large granular lymphocytic leukemia.

Genetic Profiling Improves Prognosis of Uveal Melanoma

May 18, 2012

Gene expression profiling (GEP) and chromosomal analysis show prognostic value in patients with uveal melanoma.

Bisphosphonates Cut Skeletal Morbidity in Multiple Myeloma

May 18, 2012

Zoledronate superior to placebo or etidronate for improving overall survival.

INTRON A SOLN MULTIDOSE PENS

Oncology > Leukemias, lymphomas, and other hematologic cancers

Interferon alfa-2b, recombinant; 18million IU, 30million IU, 60million IU; per pen; for SC inj; contains m-cresol.

Leucovorin

Oncology > Cytoprotective and supportive care agents

Leucovorin calcium 100mg/vial, 350mg/vial; lyophilized pwd for IV or IM inj after reconstitution; preservative-free.

SOLTAMOX ORAL SOLUTION

Oncology > Breast cancer

Tamoxifen (as citrate) 10mg/5mL; licorice and aniseed flavors; sugar-free; contains alcohol.

Thiotepa

Oncology > Bladder, kidney, and other urologic cancers

Thiotepa 15mg; per vial; lyophilized pwd for IV, intravesical, or intracavitary administration after reconstitution.

XALKORI

Oncology > Respiratory and thoracic cancers

Crizotinib 200mg, 250mg; caps.

Oncology > Cytoprotective and supportive care agents

Bisphosphonates (eg, Aredia, Zometa) may inhibit the activation of cancer-associated proteins through the suppression of geranyl-geranylation and farnesylation or inhibit ...
more »

'Teachable Moments' for Smoking Cessation in Patients Diagnosed with Cancer Underutilized

Debra Hughes February 16, 2012

Less than one-fifth (18.1%) of healthcare providers reported high levels of confidence in their ability to counsel patients with cancer who smoke to quit smoking, a survey published in The Oncologist online February 14 has found.

Prognostic Potential of Cell Surface Markers and Pim Kinases in Multiple Myeloma

May 11, 2012

A look at the following clinical trial: Prognostic Potential of Cell Surface Markers and Pim Kinases in Multiple Myeloma

Clinical Study of PM01183 in Patients With Acute Leukemia

May 10, 2012

A look at the following clinical trial: Clinical Study of PM01183 in Patients With Acute Leukemia

Diuretics for Hypertension

December 30, 2011

Hypertension dosing regiment chart for loop, potassium-sparing, and thiazide-like diuretics.

Calcium Channel Blockers Chart

December 30, 2011

Calcium channel blockers (CCB) used to treat hypertension (HTN) including benzothiazepines, dihydropyridines, and diphenylalkylamines.

Beta Blockers

December 30, 2011

Beta blocker pharmacokinetic comparison chart.

Angiotensin-Converting Enzyme (ACE) Inhibitors for Hypertension

December 30, 2011

Angiotensin-Converting Enzyme (ACE) Inhibitors and ACEI Combination Therapy Hypertension Dosing Chart.

Angiotensin II Receptor Blocker (ARB) for Hypertension

December 30, 2011

Angiotensin II Receptor Blockers (ARB) and ARB Hypertension dosing.


© 2012 Haymarket Media, Inc.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions